ArticleAcute and Repeated Treatment with 5-PAHSA or 9-PAHSA Isomers Does Not Improve Glucose Control in Mice

Add time:08/23/2019    Source:sciencedirect.com

SummaryFatty acid esters of hydroxylated fatty acids (FAHFAs) were discovered as a novel class of endogenous mammalian lipids whose profound effects on metabolism have been shown. In the current study, in vitro and in vivo the metabolic effects of two of these FAHFAs, namely palmitic acid-5- (or -9) -hydroxy-stearic acid (5- or 9-PAHSA, respectively) were profiled. In DIO mice fed with differentially composed low- or high-fat diets, acute and subchronic treatment with 5-PAHSA and 9-PAHSA alone, or in combination, did not significantly improve the deranged metabolic status. Neither racemic 5- or 9-PAHSA, nor the enantiomers were able to: (1) increase basal or insulin-stimulated glucose uptake in vitro, (2) stimulate GLP-1 release from GLUTag cells, or (3) induce GSIS in rat, mouse, or human islets or in a human pancreatic β cell line. Therefore, our data do not support the further development of PAHSAs or their derivatives for the control of insulin resistance and hyperglycemia.

We also recommend Trading Suppliers and Manufacturers of Octadecanoic acid, 9(or 10)-(sulfooxy)-, ammonium sodium salt (cas 111001-43-5). Pls Click Website Link as below: cas 111001-43-5 suppliers

Prev:Clay and ammonium catalyzed reactions of alkanols, alkanoic acids and esters under flash pyrolytic conditions
Next:Original Research PaperThe use of zeta potential to investigate the pKa of saturated fatty acids)